1-115033402-A-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000549.5(TSHB):āc.40A>Gā(p.Thr14Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.967 in 1,613,386 control chromosomes in the GnomAD database, including 755,109 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T14I) has been classified as Uncertain significance.
Frequency
Consequence
NM_000549.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TSHB | NM_000549.5 | c.40A>G | p.Thr14Ala | missense_variant | 2/3 | ENST00000256592.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TSHB | ENST00000256592.3 | c.40A>G | p.Thr14Ala | missense_variant | 2/3 | 5 | NM_000549.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.977 AC: 148506AN: 152070Hom.: 72526 Cov.: 32
GnomAD3 exomes AF: 0.971 AC: 244090AN: 251258Hom.: 118616 AF XY: 0.969 AC XY: 131563AN XY: 135784
GnomAD4 exome AF: 0.966 AC: 1412161AN: 1461198Hom.: 682519 Cov.: 49 AF XY: 0.966 AC XY: 702382AN XY: 726904
GnomAD4 genome AF: 0.977 AC: 148629AN: 152188Hom.: 72590 Cov.: 32 AF XY: 0.976 AC XY: 72640AN XY: 74412
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 12, 2018 | This variant is associated with the following publications: (PMID: 28515030, 27884173, 10411113, 20981092) - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Isolated thyroid-stimulating hormone deficiency Benign:2
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 10, 2021 | - - |
Congenital hypothyroidism Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at